1.Karahan AY, Kaya B, Kuran B, Altındag O, Yildirim P, Dogan SC, et al. Common Mistakes in the Dual-Energy X-ray Absorptiometry (DXA) in Turkey. A Retrospective Descriptive Multicenter Study. Acta Medica. 2017;59:117–23.
2.Angthong C, Angthong W, Harnroongroj T, Harnroongroj T. A comparison of survival rates for hip fracture patients with or without subsequent osteoporotic vertebral compression fractures. Tohoku Journal of Experimental Medicine. 2012;226:129.
3.Chao CT, Chiang CK, Huang JW, Chan DC, group COoGNiNTUHs. Effect of Frail Phenotype on Bone Mass and Vertebral Compression Fracture in Individuals Undergoing Dialysis. J Am Geriatr Soc. 2016;64:e19–21.
4.Oei L, Koromani F, Rivadeneira F, Zillikens MC, Oei EH. Quantitative imaging methods in osteoporosis. Quant Imaging Med Surg. 2016;6:680–98.
5.Licks R, Licks V, Ourique F, Radke BH, Fontanella V. Development of a prediction tool for low bone mass based on clinical data and periapical radiography. 2014.
6.Beaton DE, Dyer S, Jiang D, Sujic R, Slater M, Sale JEM, et al. Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening program. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25:289–96.
7.Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–9.
8.Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005;90:2787–93.
9.Seeman E. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone. 2007;41:308–17.
10.Yamaga A, Taga M, Minaguchi H, Sato K. Changes in bone mass as determined by ultrasound and biochemical markers of bone turnover during pregnancy and puerperium: a longitudinal study. J Clin Endocrinol Metab. 1996;81:752–6.
11.Karchevsky M, Babb JS, Schweitzer ME. Can diffusion-weighted imaging be used to differentiate benign from pathologic fractures? A meta-analysis. Skeletal Radiology. 2008;37:791–5.
12.Gajewicz W, Papierz W, Szymczak W, Goraj B. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes. Med Sci Monit. 2003;9:97–105.
13.O’Brien CM, Vargis E, Paria BC, Bennett KA, Mahadevan-Jansen A, Reese J. Raman spectroscopy provides a noninvasive approach for determining biochemical composition of the pregnant cervix in vivo. Acta Paediatrica. 2014;103:715–21.
14.Hollak C, Maas M, Akkerman E, Den HA, Aerts H. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease. Blood Cells Molecules & Diseases. 2001;27:1005–12.
15.Brasselet S, Ferrand P, Kress A, Wang X, Ranchon H, Gasecka A. Imaging Molecular Order in Cell Membranes by Polarization-Resolved Fluorescence Microscopy; 2012.
16.Ishida Y, Kawai S. [Diagnostic imaging in osteoporosis (CT and MRI)]. Clin Calcium. 2001;11:1561–7.
17.Hong J, Hipp JA, Mulkern RV, Jaramillo D, Snyder BD. Magnetic resonance imaging measurements of bone density and cross-sectional geometry. Calcif Tissue Int. 2000;66:74–8.
18.Ho KY, Hu HH, Keyak JH, Colletti PM, Powers CM. Measuring bone mineral density with fat-water MRI: comparison with computed tomography. Journal of magnetic resonance imaging: JMRI. 2013;37:237–42.
19.Lekadir K, Hoogendoorn C, Armitage P, Whitby E, King D, Dimitri P, et al. Estimation of trabecular bone parameters in children from multisequence MRI using texture-based regression. Med Phys. 2016;43:3071–9.
20.Baum T, Carballido-Gamio J, Huber MB, Müller D, Monetti R, Räth C, et al. Automated 3D trabecular bone structure analysis of the proximal femur—prediction of biomechanical strength by CT and DXA. Osteoporosis International. 2010;21:1553–64.
21.Kang GH, Cruite I, Shiehmorteza M, Wolfson T, Gamst AC, Hamilton G, et al. Reproducibility of MRI‐determined proton density fat fraction across two different MR scanner platforms. Journal of Magnetic Resonance Imaging. 2011;34:928–34.
22.Becker C, Baltzer AW, Schneppenheim M, Becker A, Assheuer J, Merk HR, et al. [Experimental validation of DXA and MRI-based bone density measurement by ash-method]. Zentralbl Chir. 2001;126:402–6.
23.Rebuzzi M, Vinicola V, Taggi F, Sabatini U, Wehrli FW, Capuani S. Potential diagnostic role of the MRI-derived internal magnetic field gradient in calcaneus cancellous bone for evaluating postmenopausal osteoporosis at 3T. Bone. 2013;57:155–63.
24.Wang S, Radiology DO. Differential Diagnosis of Vertebral Compression Fractures Caused by Osteoporosis and Bone Metastases on MRI. Practical Journal of Cancer. 2014.
25.Cicala D,., Briganti F,., Casale L,., Rossi C,., Cagini L,., Cesarano E,., et al. Atraumatic vertebral compression fractures: differential diagnosis between benign osteoporotic and malignant fractures by MRI. Musculoskeletal Surgery. 2013;97:169–79.
26.Cho WI, Chang UK. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures. Journal of Neurosurgery Spine. 2011;14:177.
27.Zhang L, Li S, Hao S, Yuan Z. Quantification of fat deposition in bone marrow in the lumbar vertebra by proton MRS and in-phase and out-of-phase MRI for the diagnosis of osteoporosis. Journal of X-Ray Science and Technology. 2016;24:257–66.